ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HIK Hikma Pharmaceuticals Plc

1,913.00
59.00 (3.18%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  59.00 3.18% 1,913.00 1,916.00 1,918.00 1,920.00 1,861.00 1,861.00 522,491 16:35:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8685 22.08 4.24B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,854p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,711.00p to 2,222.00p.

Hikma Pharmaceuticals currently has 221,081,676 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.24 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 22.08.

Hikma Pharmaceuticals Share Discussion Threads

Showing 1551 to 1573 of 1875 messages
Chat Pages: Latest  63  62  61  60  59  58  57  56  55  54  53  52  Older
DateSubjectAuthorDiscuss
13/4/2022
12:06
Must be a substantial holder dumping
scepticalinvestor
13/4/2022
09:10
Buybacks continues shareprice not moving at least they are buying back cheap, normally companies having buybacks pay top price.
montyhedge
10/4/2022
11:25
British Bulls made this a buy on Friday:
netcurtains
08/4/2022
12:13
Once again the Cinderella of the Pharma lagging behind, one day Cinders will join the ball. Forecast p.e 12.2.
montyhedge
08/4/2022
08:41
Its working for GSK on most days (and also it appears to be working for PEARSON).
I'm thinking SI, it probably will work for HIK too... Touchwood!

netcurtains
08/4/2022
08:18
Share buyback not exactly working lol
scepticalinvestor
04/4/2022
12:31
According to this article forecast forward p.e 12.2, if correct that is ridiculously cheap for a FTSE 100 pharma stock.https://www.fool.co.uk/2022/02/18/2-cheap-uk-stocks-to-buy-for-the-rotation-into-value/
montyhedge
04/4/2022
11:29
I agree and with a bit of luck we’ll be proven right, I was referring to the previous tedious post.
blue59
04/4/2022
10:35
blue: That is the point, asuming there is nothing fundamentally wrong with HIK, it does appear to be quite cheap.

HIK Pe 15
GSK Pe 19
AZN Pe (dont totally nuts).

Of the three, if nothing wrong with HIK, then HIK is probably looking pretty good.

netcurtains
04/4/2022
09:38
Year on year GSK up 27% and a 4.8% yield, HIK down 14% and a 2% yield. Curious thing to bring up if you’re touting a stock!
blue59
29/3/2022
10:49
Safe, boring, flying under the radar.But 15 years of continuous dividend growth.GSK shareprice below what it was 30 years ago. Not Hikma.
montyhedge
29/3/2022
08:59
Looking at the transactions, there is no pattern.
HIK start buying their shares in small batches from 8:00am and go on to 4:30pm.
So all things being equal, (days where buyers and sellers are roughly equal),
the price should slowly drift upwards as long as the buyback continues and no bad news.

netcurtains
28/3/2022
13:56
I wonder if there will be an afternoon bounce.
netcurtains
28/3/2022
13:31
Once again missing the party, Cinderella of the FTSE 100.
montyhedge
22/3/2022
14:49
Agree with Peel Hunt who said under appreciated and flying under the radar.https://www.fool.co.uk/2022/02/18/2-cheap-uk-stocks-to-buy-for-the-rotation-into-value/
montyhedge
22/3/2022
14:44
I could see this on its way back to 2700p, with a fair wind behind it.
montyhedge
21/3/2022
10:39
US fund manager sold 5% been keeping shareprice low, so that's why I reckon they fell from 2700p to 2000p, did they have to sell? Certainly wasn't because of the good figures for Hikma. But with buybacks taking us to mid June, we should be back to the right level coming months.
montyhedge
17/3/2022
13:50
Right price for Hikma should be around 2600p on fundamentals but for some reason Hikma lowest rated pharma. Still buybacks picking up their own shares cheap. Will help of course eps and even lower p.e.
montyhedge
17/3/2022
13:15
Ex div day so this is up 30p??
robertball
17/3/2022
12:59
My calculations buybacks until June.Helps to underpin shareprice especially when low volume
montyhedge
14/3/2022
16:16
Weaker sterling good for shareholders, bigger profits and bigger dividends.Be nice to see 1.29 to the dollar.
montyhedge
14/3/2022
10:25
Ex div 17th March 36c, I bet they will be above 2000p, after ex div.
montyhedge
11/3/2022
15:08
Resistance above 2000p bloody irritating
scepticalinvestor
Chat Pages: Latest  63  62  61  60  59  58  57  56  55  54  53  52  Older

Your Recent History

Delayed Upgrade Clock